大研医器（7775） – (Delayed)Summary of Non-Consolidated Financial Results for the Nine Months Ended December 31, 2021

Translation Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail. Summary of Non-Consolidated Financial Results for the Nine Months Ended December 31, 2021 (Based on Japanese GAAP) DAIKEN MEDICAL CO., LTD. Company name: Stock exchange listing: Tokyo Stock code: Representative: 7775 President URL http://www.daiken-iki.co.jp Keiichi Yamada Inquiries: General Manager Finance and Accounting Division Toshikazu Itami TEL 0725-30-3574 January 31, 2022Scheduled date to file Quarterly Securities Report: Scheduled date to commence dividend payments: February 1, 2022 – Preparation of supplementary material on quarterly financial results: No Holding of quarterly financial results meeting: No 1. Non-consolidated financial results for the nine months ended December 31, 2021 (from April 1, 2021 to December 31, 2021) (1) Non-consolidated operating results (cumulative) Percentages indicate year-on-year changesNine months ended December 31, 2021 Nine months ended December 31, 2020 Net sales Operating profit Ordinary profit Profit Millions of yen 6,420 6,015 % Millions of yen 933 6.7 846 (7.5)% Millions of yen 933 882 10.3 (11.7)% Millions of yen 662 5.8 632 (9.3)% 4.7 (8.9)(Amounts less than one million yen are rounded down)Nine months ended December 31, 2021 Nine months ended December 31, 2020 (2) Non-consolidated financial position As of December 31, 2021 As of March 31, 2021 2. Cash dividends Earnings per share Diluted earnings per share Yen 23.05 22.01 Yen – – Total assets Net assets Equity ratio Millions of yen 10,752 10,752 Millions of yen 6,273 6,182 % 58.3 57.5 1st quarter-end 2nd quarter-end 3rd quarter-end Fiscal year-end Total Annual dividends per share Year ended March 31, 2021 Year ending March 31, 2022 Year ending March 31, 2022 (Forecast) Yen – – Yen 9.00 9.00 Yen – – Yen 11.00 11.00 Yen 20.00 20.00 3. Forecast of non-consolidated financial results for the year ending March 31, 2022 (from April 1, 2021 to March 31, 2022) Percentages indicate year-on-year changesNet sales Operating profit Ordinary profit Profit Earnings per share Full year Millions of yen 8,400 % Millions of yen 1,100 6.8 % Millions of yen 1,100 19.4 % Millions of yen 770 14.9 % 14.0 Yen 26.80 14. Notes (1) Application of special accounting methods for preparing quarterly non-consolidated financial statements: Yes (2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements Changes in accounting policies due to revisions to accounting standards and other regulations: Changes in accounting policies due to other reasons: Changes in accounting estimates: Restatement of prior period financial statements: Yes No No No (3) Number of issued shares (common shares) Total number of issued shares at the end of the period (including treasury shares) As of December 31, 2021 31,840,000 shares As of March 31, 2021 31,840,000 shares Number of treasury shares at the end of the period As of December 31, 2021 3,111,559 shares As of March 31, 2021 3,111,559 shares Average number of shares during the period (cumulative from the beginning of the fiscal year) Nine months ended December 31, 2021 28,728,441 shares Nine months ended December 31, 2020 28,728,441 shares 2Quarterly non-consolidated financial statements Non-consolidated balance sheets As of March 31, 2021 As of December 31, 2021 (Thousands of yen) Assets Current assets Cash and deposits Notes and accounts receivable – trade Electronically recorded monetary claims – operating Finished goods Work in process Raw materials Other Allowance for doubtful accounts Total current assets Non-current assets Property, plant and equipment Buildings, net Land Other, net Total property, plant and equipment Intangible assets Investments and other assets Deferred tax assets Other Allowance for doubtful accounts Total investments and other assets Total non-current assets Total assets 2,170,643 1,597,757 989,922 891,412 86,665 443,833 92,402 (87) 6,272,550 2,019,367 1,703,670 502,053 4,225,091 21,723 166,802 91,404 (24,650) 233,555 4,480,370 10,752,921 2,081,992 1,463,428 1,096,225 958,529 78,831 501,947 177,089 (87) 6,357,956 1,959,730 1,703,670 494,216 4,157,618 15,935 166,802 78,360 (24,650) 220,511 4,394,065 10,752,021 3 As of March 31, 2021 As of December 31, 2021 (Thousands of yen) Liabilities Current liabilities Notes and accounts payable – trade Electronically recorded obligations – operating Short-term borrowings Current portion of long-term borrowings Income taxes payable Accrued expenses Provision for Sales allowance Asset retirement obligations Other Total current liabilities Non-current liabilities Long-term borrowings Other Total non-current liabilities Total liabilities Net assets Shareholders’ equity Share capital Capital surplus Retained earnings Treasury shares Total shareholders’ equity Share acquisition rights Total net assets Total liabilities and net assets 849,189 141,925 1,000,000 704,034 111,074 179,500 179,346 6,738 175,208 3,347,018 1,177,859 45,768 1,223,627 4,570,645 495,875 400,875 7,112,107 (1,826,582) 6,182,275 – 6,182,275 10,752,921 456,594 591,656 1,500,000 551,434 167,885 82,923 – – 301,286 3,651,779 788,371 38,203 826,574 4,478,353 495,875 400,875 7,199,674 (1,826,582) 6,269,841 3,825 6,273,667 10,752,021 4Non-consolidated statements of income (cumulative) (Thousands of yen) Nine months ended December 31, 2020 Nine months ended December 31, 2021 Net sales Cost of sales Gross profit Operating profit Non-operating income Interest income Compensation income Selling, general and administrative expenses Gain on forfeiture of unclaimed dividends Subsidy income Miscellaneous income Other Total non-operating income Non-operating expenses Interest expenses Other Total non-operating expenses Ordinary profit Extraordinary losses Loss on retirement of non-current assets Total extraordinary losses Profit before income taxes Income taxes Profit 6,015,232 3,321,998 2,693,234 1,846,676 846,557 0 449 1,059 36,072 760 551 38,893 2,802 – 2,802 882,649 4,009 4,009 878,639 246,345 632,294 6,420,476 3,579,100 2,841,375 1,907,700 933,675 0 900 796 – 1,027 181 2,905 2,871 50 2,922 901 901 933,658 932,757 270,622 662,135 5